Keystone Symposia

Keystone Symposia Scientific Advisory Board

The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.

To learn more about the functions of the SAB, please click here.

Board of Directors are denoted with a # following their name.

E. Dale Abel, M.D., Ph.D.#
Director F.O.E. Diabetes Research Center
Professor of Medicine and Biochemistry
University of Iowa, Carver College of Medicine

George Addona, Ph.D.
Associate Vice President
Merck Research Labs

Clement Adebamowo, B.M., Ch.B., Hons, Sc.D.
Professor Epidemiology and Public Health
Associate Director Population Science,
Greenebaum Comprehensive Cancer Center
Member, Institute of Human Virology
University of Maryland School of Medicine

Luciano Adorini, M.D.
Chief Scientific Officer
Preclinical Research
Intercept Pharmaceuticals, Inc.

Muhammad Al-Hajj, Ph.D.
Senior Vice President Translational Medicine
Translational Sciences
Autolus Therapeutics

Eric H. Baehrecke, Ph.D.
Molecular, Cell and Cancer Biology
University of Massachusetts Medical School

Jacques F. Banchereau, Ph.D.
Professor and Director of Immunological Sciences
The Jackson Laboratory for Genomic Medicine

Dominic P. Behan, Ph.D., D.Sc.
Chief Executive Officer
Sentia Medical Sciences, Inc.

Yasmine Belkaid, Ph.D.
Director NIAID Microbiome Program
Chief Mucosal Immunology Section
Laboratory of Parasitic Disease
NIAID, National Institutes of Health

Ralph A. Bradshaw, Ph.D.#
Professor Emeritus
Department of Physiology and Biophysics
University of California, Irvine

Cherié L. Butts, Ph.D.#
Medical Director
Digital & Quantitative Medicine
Biogen Inc

Robert Califf, M.D., MACC#
Head of Medical Strategy and Policy for Verily and Google Health
Verily Life Sciences, Google Health

Mark Cobbold, M.D., Ph.D.
Vice President
Oncology ICA Discovery

Ian M. Colrain, Ph.D.#
President SRI International
SRI Biosciences

Roger D. Cone, Ph.D.
Life Sciences Institute
University of Michigan

Feng Cong, Ph.D.
Chemical Biology & Therapeutics
Novartis Institutes for BioMedical Research

John E. Connolly, Ph.D.
Chief Scientific Officer
Research & Development
Tessa Therapeutics Ltd.

Rodrigo Corrêa-Oliveira, Ph.D.
Vice President
Research and Biological Collections

Ana Maria Cuervo, M.D., Ph.D.
Professor, Department of Developmental and Molecular Biology
Co-Director, Institute for Aging Studies
Albert Einstein College of Medicine

Robertus de Bruin, Ph.D.
Professor, Molecular Cancer Biology
MRC Laboratory for Molecular Cell Biology
University College London

Robert J. Deans, Ph.D.
Chief Technology Officer
BlueRock Therapeutics

Russell A. DeBose-Boyd, Ph.D.
Molecular Genetics
University of Texas Southwestern Medical Center

Edward A. Dennis, Ph.D.#
Chancellor Distinguished Professor
Chemistry, Biochemistry and Pharmacology
School of Medicine
University of California, San Diego

Vishva M. Dixit, M.D.#
Vice President, Early Discovery Research and Physiological Chemistry
Genentech, Inc.

Aris N. Economides, Ph.D.
Vice President
Regeneron Pharmaceuticals, Inc.

Peter M. Finan#
Epidarex Capital

Kelly A. Frazer, Ph.D.
Professor, Pediatrics
Director, Institute for Genomic Medicine
University of California San Diego School of Medicine

Adolfo García-Sastre, Ph.D.
Mount Sinai School of Medicine

Tariq Ghayur, Ph.D.
Senior Research Fellow
AbbVie Inc.

Paloma Giangrande, Ph.D.
Director, Rare Disease, Moderna
Associate Professor, Internal Medicine
University of Iowa

Geoffrey S. Ginsburg, M.D., Ph.D.#
The Duke Center for Applied Genomics & Precision Medicine
Duke University

Margaret A. Goodell, Ph.D.#
Professor and Chair
Department of Molecular and Cellular Biology
Director of Stem Cells & Regenerative Medicine Center
Vivian L. Smith Chair of Regenerative Medicine
Baylor College of Medicine

Curtis C. Harris, M.D.#
Chief, Laboratory of Human Carcinogenesis
NCI / National Institutes of Health

Tim Harris, Ph.D.
Executive Vice President of Research and Development
Bioverativ Therapeutics

Lora K. Heisler, Ph.D.
Chair in Human Nutrition
Obesity and Food Choice
Rowett Institute, University of Aberdeen

De' Broski R. Herbert, Ph.D.
Associate Professor of Infectious Immunology
School of Veterinary Medicine
University of Pennyslvania

Linda Slanec Higgins, Ph.D.
Senior Vice President , Biology
Gilead Sciences, Inc.

Sean Hill, Ph.D.
Director, Krembil Centre for Neuroinformatics
Centre for Addiction and Mental Health
Professor, Department of Psychiatry, University of Toronto
Professor, Blue Brain Project, École Polytechnique Fédérale de Lausanne (EPFL)

Robert J. Hofmeister, Ph.D.
Chief Scientific Officer
TCR2 Therapeutics

Pamela M. Holland, Ph.D.
Vice President
Cancer Biology
Surface Oncology

Michael J. Holtzman, M.D.
Herman and Selma Seldin Professor of Medicine
Director, Pulmonary and Critical Care Medicine
Washington University in St. Louis

Tony Hunter, Ph.D.#
Professor and Principal Investigator
Molecular Cellular Biology Laboratories
The Salk Institute for Biological Sciences

Aron B. Jaffe, Ph.D.
Third Rock Ventures

Thale C. Jarvis, Ph.D.#
Chief Scientific Officer
Keystone Symposia

Sally John, Ph.D.
Vice President, Translational Biology
Research and Early Development

Deborah L. Johnson, Ph.D.#
President and Chief Executive Officer
Keystone Symposia on Molecular and Cellular Biology

Takashi Kadowaki, M.D., Ph.D.
Professor and Chairman
Graduate School of Medicine, Diabetes and Metabolic Diseases
University of Tokyo

Christopher L. Karp, M.D.
Director, Global Health Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Véronique Kiermer, Ph.D.#
Executive Editor and Publisher
Publishing and Editorial
Public Library of Science (PLOS)

Karla A. Kirkegaard, Ph.D.
Violetta Horton Professor
Genetics & Microbiology & Immunology
Stanford University School of Medicine

Melanie A. Kleinschek, D.V.M., Ph.D.
VP, Science and Innovation Strategy
Theravance Biopharma

Mark Kowala, B.Sc., Ph.D.
Chief Scientific Officer
Eli Lilly Research Lab

Martin Kussmann, Ph.D.
Chief Scientific Officer
Diabetes Center Bern

Jeffery L. Kutok, M.D., Ph.D.
Chief Scientific Officer
Infinity Pharmaceuticals, Inc.

Tony K.T. Lam, Ph.D.
Professor and J.K. McIvor Endowed Chair in Diabetes Research
Canada Research Chair in Obesity
Associate Director, Banting and Best Diabetes Centre
Advanced Diagnostics and Metabolism
Toronto General Research Institute

Jan E. Leach, Ph.D.
University Distinguished Professor
Bioagricultural Sciences
Colorado State University

Dangsheng Li, Ph.D.
Deputy Editor-in-Chief
Cell Research
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

Sarah Lively, Ph.D.
Executive Director
Head, San Francisco Site
ChemPartner Corporation

Juan Carlos López, Ph.D.#
Haystack Science

Patrick Mayes, Ph.D.
Executive Director
Immuno-Oncology Antibodies
Incyte Research Institute

M. Juliana McElrath, M.D., Ph.D.
Senior Vice President, Director and Member
Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center

Juanita L. Merchant, M.D., Ph.D.
Chief, Division of Gastroenterology & Hepatology
University of Arizona College of Medicine

Tara Mirzadegan, Ph.D.
Senior Director
Janssen R&D: Pharmaceutical Companies of Johnson & Johnson

Valerie Mizrahi, Ph.D.
Institute of Infectious Disease and Molecular Medicine (IDM)
University of Cape Town

Craig Monell, Ph.D.
Vice President
Business Operations/R&D
BioLegend, Inc.

Walter H. Moos, Ph.D.#
Managing Director, Pandect Bioventures
CEO, ShangPharma Innovation
Professor (adj.), University of California, San Francisco
President (ret.), SRI Biosciences

Richard A. Morgan, Ph.D.
Senior Vice President
Editas Medicine

Dominik Mumberg, Ph.D.
Vice President
Oncology II
Bayer AG

Leon O. Murphy, Ph.D.
Chief Scientific Officer
Casma Therapeutics

Anthony J. Muslin, M.D.
Vice President, Head
Cardiovascular and Metabolism Therapeutic Area
Sanofi Global Research & Development

Vic E. Myer, Ph.D.

Lee A. Niswander, Ph.D.
Professor and Chair
Molecular, Cellular and Developmental Biology
University of Colorado Boulder

Anne O'Garra, Ph.D., FRS, FMedSci#
Associate Research Director
The Francis Crick Institute
Mill Hill Laboratory

Wenjun Ouyang, Ph.D.
Executive Director
Inflammation and Oncology, Research
Amgen, Inc.

Deborah Palliser, Ph.D.
Immunology Strategy Lead
Rare Diseases Drug Discovery Unit

Paul W. H. I. Parren, Ph.D.
Department of Immunohematology and Blood Transfusion
Leiden University Medical Center

Mark J. Powers, Ph.D.
Senior Director, Research and Development- Cell Biology
Thermo Fisher Scientific

Bali Pulendran, Ph.D.
Professor, Pathology and of Microbiology and Immunology
Stanford University School of Medicine

Michael Quigley, Ph.D.
Vice President
Oncology Discovery Biology
Bristol-Myers Squibb Company

Michael H. Rabinowitz, Ph.D.
Vice President
Akebia Therapeutics, Inc

Laszlo Radvanyi, Ph.D.
President and Scientific Director
Ontario Institute for Cancer Research

Sridhar Ramaswamy, M.D.
Entrepreneur in Residence
Google Ventures

Richard M. Ransohoff, M.D.
Third Rock Ventures

Rino Rappuoli, Ph.D.
Chief Scientist and Head of External Research and Development
GlaxoSmithKline Vaccines

Bing Ren, Ph.D.
Ludwig Institute for Cancer Research

Christopher J. Rhodes, BSc, PhD
Chief Scientist, Cardiovascular, Renal & Metabolism, BioPharmaceuticals R&D, AstraZeneca
Professor, University of Chicago

Mark Rolfe, Ph.D.
Corporate Vice President
Research & Early Development
Celgene Corporation

Cristina M. Rondinone, Ph.D.
Cellarity Inc.

Thomas J. Schuetz, M.D., Ph.D.
Co-Founder, Chief Executive Officer, Director
Compass Therapeutics

Janine Schuurman, Ph.D.
Corporate Vice President
Research and Innovation

Ali Shilatifard, Ph.D.
Robert Francis Furchgott Professor
Chairman, Department of Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine

Barry P. Sleckman, M.D., Ph.D.
Director, O'Neal Comprehensive Cancer Center
University of Alabama Birmingham School of Medicine

Hans Ulrich Stilz, Ph.D.
Vice President
R&D Innovation and Outreach
Novo Nordisk A/S

Boris Striepen, Ph.D.
Professor of Microbiology and Immunology
Department of Pathobiology
School of Veterinary Medicine
University of Pennsylvania

Lynda M. Stuart, M.D., Ph.D.
Deputy Director
Global Health, Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Lori Sussel, Ph.D.
Director of Research
Basic and Translational Research Division, Barbara Davis Center
University of Colorado Anschutz Medical Campus

Eric E. Swayze, Ph.D.
Senior Vice President of Research
Ionis Pharmaceuticals, Inc.

Paul K.H. Tam, ChM
Li Shu-Pui Professor and Chair of Pediatric Surgery
Department of Surgery
Director, Dr. Li Dak Sum Research Centre
The University of Hong Kong-Karolinska Institutet Collaboration in Regenerative Medicine

Cormac Taylor, Ph.D.
Professor, Cellular Physiology
University College Dublin

Kathrin Tissot, M.D., Ph.D.
Business Team Head
MorphoSys AG

Cornelia Liu Trimble, M.D.
Gynecology and Obstetrics, Oncology, and Pathology
Johns Hopkins University School of Medicine

Fred Van Goor, Ph.D.
Principal Research Fellow
Vertex Pharmaceuticals Incorporated

Yibin Wang, Ph.D.
Anesthesiology, Physiology and Medicine
University of California, Los Angeles
David Geffen School of Medicine

Andrew B. Ward, Ph.D.
Integrative Structural and Computational Biology
The Scripps Research Institute

Stephanie Wengert Watts, Ph.D.
Professor, Assistant Dean
Pharmacology & Toxicology
Michigan State University

Michael A. White, Ph.D.
VP and Chief Scientific Officer
Tumor Cell Biology, Oncology Research and Development Group
Pfizer, Inc.

Charles E. Whitehurst, Ph.D.
Senior Associate Director
Immunology and Respiratory
Boehringer Ingelheim Pharmaceuticals, Inc.

Joseph C. Wu, M.D., Ph.D.
Professor and Director of Stanford Cardiovascular Institute
Medicine and Radiology
Stanford University School of Medicine

Xuebiao Yao, Ph.D.
Professor and Head
Cellular Dynamics
University of Science & Technology of China

Bei B. Zhang, Ph.D.#
Vice President, Metabolic Research
Worldwide Research and Development
Internal Medicine
Pfizer Inc.

Juleen R. Zierath, Ph.D.#
Department of Molecular Medicine and Surgery
Karolinska Institutet

Arturo Zychlinsky, Ph.D.
Cellular Microbiology
Max Planck Institute for Infection Biology

plus representatives to be announced from:
Sangamo Therapeutics, Inc.
Ultragenyx Pharmaceutical Inc.